Table of contents
December 2001 Vol 1 No 3
In this issue
p171 | doi:10.1038/35106077
Research Highlights
Therapeutics: Nuclear power
p173 | doi:10.1038/35106024
Therapeutic strategies: Gut reaction
p174 | doi:10.1038/35106006
Tumour suppressors: One-hit wonders?
p174 | doi:10.1038/35106021
Drug resistance: ABL to resist
Immunotherapy: One–two punch
p176 | doi:10.1038/35106003
Trial Watch
Vaccine provides hope for pancreatic cancer | New way to target the RAS pathway | Immunotherapy for metastasis
p176 | doi:10.1038/35106052
Mouse models: Of mice and moles
p177 | doi:10.1038/35106018
Breast cancer: Team effort
p177 | doi:10.1038/35106027
Therapeutic strategies: Prescription for transcription
p178 | doi:10.1038/35106030
News in Brief
Methylation | Epidemiology | Diagnostics | Radiation resistance
p178 | doi:10.1038/35106054
P53 regulation: Another link in the chain
p179 | doi:10.1038/35106033
Web Watch
Chopping and changing
p179 | doi:10.1038/35106056
Reviews
The promise of retinoids to fight against cancer
Lucia Altucci & Hinrich Gronemeyer
p181 | doi:10.1038/35106036
Histone deacetylases and cancer: causes and therapies
Paul A. Marks, Richard A. Rifkind, Victoria M. Richon, Ronald Breslow, Thomas Miller & William K. Kelly
p194 | doi:10.1038/35106079
Milestones in cell division : Cell senescence and cancer
Nicole F. Mathon & Alison C. Lloyd
p203 | doi:10.1038/35106045
FRA3B and other common fragile sites: the weakest links
Kay Huebner & Carlo M. Croce
p214 | doi:10.1038/35106058
Milestones in cell division : To cycle or not to cycle: a critical decision in cancer
Marcos Malumbres & Mariano Barbacid
p222 | doi:10.1038/35106065
Perspectives
Opinion
Assessing TP53 status in human tumours to evaluate clinical outcome
Thierry Soussi & Christophe Béroud
p233 | doi:10.1038/35106009
Timeline
Comprehensive Cancer Centres and the war on cancer
David Nathan & Edward J. Benz, Jr
p240 | doi:10.1038/35106102
Timeline
Chromosome translocations: dangerous liaisons revisited
Janet D. Rowley
p245 | doi:10.1038/35106108